Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration	CALB1 CALB2	4.32e-06	2	42	2	GO:0099534
GeneOntologyMolecularFunction	calcium ion binding involved in regulation of cytosolic calcium ion concentration	CALB1 CALB2	4.32e-06	2	42	2	GO:0099510
GeneOntologyMolecularFunction	glycogen phosphorylase activity	PYGB PYGM	1.29e-05	3	42	2	GO:0008184
GeneOntologyMolecularFunction	1,4-alpha-oligoglucan phosphorylase activity	PYGB PYGM	4.30e-05	5	42	2	GO:0004645
GeneOntologyMolecularFunction	small GTPase binding	DOCK1 GAPVD1 RABGAP1 TAMALIN EXPH5 PRKACA	5.31e-05	321	42	6	GO:0031267
GeneOntologyMolecularFunction	actin binding	MACF1 PRKCE SORBS1 MYO1E MYO1H ARPC2 MYO1F	5.70e-05	479	42	7	GO:0003779
GeneOntologyMolecularFunction	microfilament motor activity	MYO1E MYO1H MYO1F	6.93e-05	38	42	3	GO:0000146
GeneOntologyMolecularFunction	cytoskeletal protein binding	MACF1 PRKCE SORBS1 RABGAP1 DYSF MYO1E MYO1H STAU2 ARPC2 MYO1F	7.17e-05	1099	42	10	GO:0008092
GeneOntologyMolecularFunction	cAMP-dependent protein kinase activity	PRKACG PRKACA	9.01e-05	7	42	2	GO:0004691
GeneOntologyMolecularFunction	GTPase binding	DOCK1 GAPVD1 RABGAP1 TAMALIN EXPH5 PRKACA	9.99e-05	360	42	6	GO:0051020
GeneOntologyMolecularFunction	actin filament binding	MACF1 MYO1E MYO1H ARPC2 MYO1F	1.10e-04	227	42	5	GO:0051015
GeneOntologyMolecularFunction	cyclic nucleotide-dependent protein kinase activity	PRKACG PRKACA	1.54e-04	9	42	2	GO:0004690
GeneOntologyMolecularFunction	AMP-activated protein kinase activity	PRKACG PRKACA	1.92e-04	10	42	2	GO:0004679
GeneOntologyMolecularFunction	vitamin binding	PAM PYGB PYGM CALB1	3.59e-04	161	42	4	GO:0019842
GeneOntologyMolecularFunction	enzyme activator activity	DOCK1 PRKCE GAPVD1 RABGAP1 MMP16 NCS1 ADAP2	3.96e-04	656	42	7	GO:0008047
GeneOntologyMolecularFunction	carbohydrate binding	PAM PYGB PYGM UAP1 GCKR	4.64e-04	310	42	5	GO:0030246
GeneOntologyMolecularFunction	calcium ion binding	PAM MACF1 CALB1 CALB2 EFHB DYSF NCS1	8.71e-04	749	42	7	GO:0005509
GeneOntologyMolecularFunction	protein kinase A regulatory subunit binding	PRKACG PRKACA	1.26e-03	25	42	2	GO:0034237
GeneOntologyMolecularFunction	ATP-dependent activity	MACF1 SRPRA MYO1E MYO1H AQR MYO1F	1.69e-03	614	42	6	GO:0140657
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYO1E MYO1H MYO1F	1.95e-03	118	42	3	GO:0003774
GeneOntologyMolecularFunction	enzyme regulator activity	DOCK1 PRKCE GAPVD1 RABGAP1 GCKR HERC1 MMP16 NCS1 ADAP2	2.35e-03	1418	42	9	GO:0030234
GeneOntologyMolecularFunction	GTPase activator activity	DOCK1 GAPVD1 RABGAP1 ADAP2	2.75e-03	279	42	4	GO:0005096
GeneOntologyMolecularFunction	molecular function activator activity	DOCK1 PRKCE GAPVD1 RABGAP1 MMP16 NCS1 ADAP2 PRKACA	3.72e-03	1233	42	8	GO:0140677
GeneOntologyMolecularFunction	kinase binding	PAM PRKCE SORBS1 GCKR NCS1 STAU2 PRKACA	3.78e-03	969	42	7	GO:0019900
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	DOCK1 GAPVD1 RABGAP1 HERC1 ADAP2	4.06e-03	507	42	5	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	DOCK1 GAPVD1 RABGAP1 HERC1 ADAP2	4.06e-03	507	42	5	GO:0030695
GeneOntologyMolecularFunction	molecular sensor activity	GCKR EFHB	4.96e-03	50	42	2	GO:0140299
GeneOntologyMolecularFunction	pyridoxal phosphate binding	PYGB PYGM	6.19e-03	56	42	2	GO:0030170
GeneOntologyMolecularFunction	vitamin B6 binding	PYGB PYGM	6.41e-03	57	42	2	GO:0070279
GeneOntologyMolecularFunction	protein kinase A binding	PRKACG PRKACA	6.63e-03	58	42	2	GO:0051018
GeneOntologyBiologicalProcess	regulation of presynaptic cytosolic calcium ion concentration	CALB1 CALB2 NCS1	1.98e-05	26	42	3	GO:0099509
GeneOntologyBiologicalProcess	carbohydrate metabolic process	PYGB PRKCE PYGM SORBS1 GCKR CHST2 DYSF PRKACA	4.08e-05	646	42	8	GO:0005975
GeneOntologyBiologicalProcess	intracellular calcium ion homeostasis	PRKCE PYGM CALB1 CALB2 NCS1 PRKACA	8.24e-05	359	42	6	GO:0006874
GeneOntologyBiologicalProcess	calcium ion homeostasis	PRKCE PYGM CALB1 CALB2 NCS1 PRKACA	1.28e-04	389	42	6	GO:0055074
GeneOntologyCellularComponent	cuticular plate	CALB1 CALB2 MYO1E	1.98e-06	13	41	3	GO:0032437
GeneOntologyCellularComponent	actin cytoskeleton	MACF1 SORBS1 CALB1 CALB2 MYO1E MYO1H ARPC2 MYO1F	1.36e-05	576	41	8	GO:0015629
GeneOntologyCellularComponent	cortical actin cytoskeleton	CALB1 CALB2 MYO1E MYO1F	3.28e-05	93	41	4	GO:0030864
GeneOntologyCellularComponent	cortical cytoskeleton	CALB1 CALB2 MYO1E MYO1F	1.17e-04	129	41	4	GO:0030863
GeneOntologyCellularComponent	presynaptic cytosol	PRKCE CALB1 NCS1	1.21e-04	49	41	3	GO:0099523
GeneOntologyCellularComponent	cAMP-dependent protein kinase complex	PRKACG PRKACA	1.67e-04	10	41	2	GO:0005952
GeneOntologyCellularComponent	actin-based cell projection	CALB1 CALB2 MYO1E MYO1H MYO1F	2.03e-04	278	41	5	GO:0098858
GeneOntologyCellularComponent	myosin complex	MYO1E MYO1H MYO1F	2.11e-04	59	41	3	GO:0016459
GeneOntologyCellularComponent	cytosolic region	PRKCE CALB1 NCS1	3.50e-04	70	41	3	GO:0099522
GeneOntologyCellularComponent	axon terminus	CALB1 CALB2 NCS1 ARPC2	7.49e-04	210	41	4	GO:0043679
GeneOntologyCellularComponent	cell cortex	MACF1 CALB1 CALB2 MYO1E MYO1F	7.60e-04	371	41	5	GO:0005938
GeneOntologyCellularComponent	glutamatergic synapse	DOCK1 PRKCE CALB1 TAMALIN NCS1 ARPC2 PRKACA	9.56e-04	817	41	7	GO:0098978
GeneOntologyCellularComponent	neuron projection terminus	CALB1 CALB2 NCS1 ARPC2	1.10e-03	233	41	4	GO:0044306
GeneOntologyCellularComponent	presynapse	PRKCE CALB1 CALB2 DYSF NCS1 ARPC2 PRKACA	1.53e-03	886	41	7	GO:0098793
GeneOntologyCellularComponent	microvillus	MYO1E MYO1H MYO1F	1.80e-03	123	41	3	GO:0005902
GeneOntologyCellularComponent	supramolecular fiber	MACF1 PYGM EFHB DYSF KLHL40 STAU2 ARPC2 MYO1F	1.81e-03	1179	41	8	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	MACF1 PYGM EFHB DYSF KLHL40 STAU2 ARPC2 MYO1F	1.88e-03	1187	41	8	GO:0099081
GeneOntologyCellularComponent	calyx of Held	CALB1 NCS1	2.27e-03	36	41	2	GO:0044305
GeneOntologyCellularComponent	filamentous actin	ARPC2 MYO1F	2.52e-03	38	41	2	GO:0031941
GeneOntologyCellularComponent	postsynapse	DOCK1 MACF1 CALB1 TAMALIN NCS1 ARPC2 PRKACA	3.35e-03	1018	41	7	GO:0098794
GeneOntologyCellularComponent	postsynaptic cytosol	CALB1 NCS1	3.52e-03	45	41	2	GO:0099524
GeneOntologyCellularComponent	ciliary base	PRKACG PRKACA	5.41e-03	56	41	2	GO:0097546
GeneOntologyCellularComponent	dendrite	CALB1 CALB2 NCS1 STAU2 ARPC2 PRKACA	6.19e-03	858	41	6	GO:0030425
GeneOntologyCellularComponent	dendritic tree	CALB1 CALB2 NCS1 STAU2 ARPC2 PRKACA	6.26e-03	860	41	6	GO:0097447
Domain	EF-hand_7	MACF1 CALB1 CALB2 EFHB NCS1	1.29e-06	85	42	5	PF13499
Domain	Glyco_trans_35	PYGB PYGM	1.48e-05	3	42	2	IPR000811
Domain	PHOSPHORYLASE	PYGB PYGM	1.48e-05	3	42	2	PS00102
Domain	Phosphorylase	PYGB PYGM	1.48e-05	3	42	2	PF00343
Domain	Glycg_phsphrylas	PYGB PYGM	1.48e-05	3	42	2	IPR011833
Domain	EF-hand_1	MACF1 CALB1 CALB2 EFHB NCS1	2.23e-05	152	42	5	PF00036
Domain	EFh	MACF1 CALB1 CALB2 EFHB NCS1	2.69e-05	158	42	5	SM00054
Domain	EF_Hand_1_Ca_BS	MACF1 CALB1 CALB2 EFHB NCS1	4.38e-05	175	42	5	IPR018247
Domain	EF_HAND_1	MACF1 CALB1 CALB2 EFHB NCS1	9.07e-05	204	42	5	PS00018
Domain	Myosin_TH1	MYO1E MYO1F	1.03e-04	7	42	2	IPR010926
Domain	Myosin_TH1	MYO1E MYO1F	1.03e-04	7	42	2	PF06017
Domain	TH1	MYO1E MYO1F	1.03e-04	7	42	2	PS51757
Domain	SH3	DOCK1 MACF1 SORBS1 MYO1E MYO1F	1.19e-04	216	42	5	PS50002
Domain	SH3_domain	DOCK1 MACF1 SORBS1 MYO1E MYO1F	1.29e-04	220	42	5	IPR001452
Domain	EF_HAND_2	MACF1 CALB1 CALB2 EFHB NCS1	1.62e-04	231	42	5	PS50222
Domain	EF_hand_dom	MACF1 CALB1 CALB2 EFHB NCS1	1.66e-04	232	42	5	IPR002048
Domain	AGC-kinase_C	PRKACG PRKCE PRKACA	2.70e-04	56	42	3	IPR000961
Domain	AGC_KINASE_CTER	PRKACG PRKCE PRKACA	2.70e-04	56	42	3	PS51285
Domain	S_TK_X	PRKACG PRKCE PRKACA	2.70e-04	56	42	3	SM00133
Domain	-	MACF1 CALB1 CALB2 EFHB NCS1	2.86e-04	261	42	5	1.10.238.10
Domain	EF-hand_6	CALB1 CALB2	3.79e-04	13	42	2	PF13405
Domain	EF-hand-dom_pair	MACF1 CALB1 CALB2 EFHB NCS1	4.42e-04	287	42	5	IPR011992
Domain	SH3_1	DOCK1 SORBS1 MYO1E MYO1F	4.95e-04	164	42	4	PF00018
Domain	SH3_9	DOCK1 SORBS1 MYO1F	7.15e-04	78	42	3	PF14604
Domain	SH3	DOCK1 SORBS1 MYO1E MYO1F	1.38e-03	216	42	4	SM00326
Domain	MYOSIN_MOTOR	MYO1E MYO1F	3.30e-03	38	42	2	PS51456
Domain	Myosin_head	MYO1E MYO1F	3.30e-03	38	42	2	PF00063
Domain	Myosin_head_motor_dom	MYO1E MYO1F	3.30e-03	38	42	2	IPR001609
Domain	MYSc	MYO1E MYO1F	3.30e-03	38	42	2	SM00242
Domain	Pkinase_C	PRKCE PRKACA	4.02e-03	42	42	2	PF00433
Pathway	KEGG_INSULIN_SIGNALING_PATHWAY	PRKACG PYGB PYGM SORBS1 PRKACA	1.31e-05	137	32	5	M18155
Pathway	REACTOME_METABOLISM_OF_CARBOHYDRATES	PRKACG PYGB PYGM GCKR CHST2 PRKACA	4.00e-05	288	32	6	M16864
Pathway	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS	PRKACG PRKACA	4.97e-05	5	32	2	M26988
Pathway	KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY	PRKACG SMARCD3 PRKACA	6.62e-05	35	32	3	M47969
Pathway	KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME	PRKACG PRKACA	1.04e-04	7	32	2	M47896
Pathway	REACTOME_DAG_AND_IP3_SIGNALING	PRKACG PRKCE PRKACA	1.07e-04	41	32	3	M512
Pathway	REACTOME_HDL_ASSEMBLY	PRKACG PRKACA	1.39e-04	8	32	2	M27840
Pathway	REACTOME_ROBO_RECEPTORS_BIND_AKAP5	PRKACG PRKACA	1.78e-04	9	32	2	M27877
Pathway	KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION	PYGB PYGM	1.78e-04	9	32	2	M47621
Pathway	KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY	PRKACG PRKACA	2.22e-04	10	32	2	M47648
Pathway	REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM	PRKACG PRKACA	3.25e-04	12	32	2	M27950
Pathway	REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE	PRKACG PRKACA	3.25e-04	12	32	2	M27363
Pathway	WP_DOPAMINE_METABOLISM	PRKACG PRKACA	3.83e-04	13	32	2	M39622
Pathway	BIOCARTA_AKAPCENTROSOME_PATHWAY	PRKACG PRKCE	4.47e-04	14	32	2	M15347
Pathway	REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS	PYGB PYGM	4.47e-04	14	32	2	M19193
Pathway	KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY	PRKACG PRKACA	5.15e-04	15	32	2	M47794
Pathway	PID_LPA4_PATHWAY	PRKCE PRKACA	5.15e-04	15	32	2	M56
Pathway	KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY	PRKACG PRKACA	5.15e-04	15	32	2	M47504
Pathway	BIOCARTA_PTDINS_PATHWAY	PRKCE TAMALIN	5.87e-04	16	32	2	MM1454
Pathway	KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY	PRKACG PRKACA	5.87e-04	16	32	2	M47551
Pathway	KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY	PRKACG PRKACA	5.87e-04	16	32	2	M47645
Pathway	KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY	PRKACG PRKACA	5.87e-04	16	32	2	M47650
Pathway	REACTOME_RAP1_SIGNALLING	PRKACG PRKACA	5.87e-04	16	32	2	M923
Pathway	REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING	PRKACG PRKACA	6.65e-04	17	32	2	M26995
Pathway	KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY	PRKACG PRKACA	6.65e-04	17	32	2	M47544
Pathway	REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY	PRKACG PRKACA	8.33e-04	19	32	2	M27841
Pathway	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB	PRKACG PRKACA	9.25e-04	20	32	2	M759
Pathway	REACTOME_GLUCOSE_METABOLISM	PRKACG GCKR PRKACA	9.25e-04	85	32	3	M1870
Pathway	REACTOME_CD209_DC_SIGN_SIGNALING	PRKACG PRKACA	1.02e-03	21	32	2	M27485
Pathway	WP_G_PROTEIN_SIGNALING	PRKACG PRKCE PRKACA	1.13e-03	91	32	3	M39426
Pathway	REACTOME_TRIGLYCERIDE_CATABOLISM	PRKACG PRKACA	1.34e-03	24	32	2	M10064
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY	PRKACG PRKACA	1.34e-03	24	32	2	M47520
Pathway	REACTOME_DARPP_32_EVENTS	PRKACG PRKACA	1.34e-03	24	32	2	M751
Pathway	WP_HIPPO_SIGNALING_REGULATION	PRKACG PRKCE PRKACA	1.40e-03	98	32	3	M39830
Pathway	REACTOME_LEISHMANIA_INFECTION	PRKACG DOCK1 ARPC2 PRKACA	1.45e-03	219	32	4	M29836
Pathway	REACTOME_GLYCOGEN_METABOLISM	PYGB PYGM	1.45e-03	25	32	2	M27857
Pathway	PID_IL3_PATHWAY	PRKACG PRKACA	1.57e-03	26	32	2	M182
Pathway	KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY	PRKACG PRKACA	1.57e-03	26	32	2	M47553
Pathway	KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY	PRKACG PRKACA	1.69e-03	27	32	2	M47518
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY	PRKACG PRKACA	1.69e-03	27	32	2	M47519
Pathway	REACTOME_SIGNALING_BY_VEGF	PRKACG DOCK1 PRKACA	1.75e-03	106	32	3	M27077
Pathway	KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY	PRKACG PRKACA	1.82e-03	28	32	2	M47647
Pathway	WP_THERMOGENESIS	PRKACG SMARCD3 PRKACA	1.85e-03	108	32	3	M39746
Pathway	WP_CANNABINOID_RECEPTOR_SIGNALING	PRKACG PRKACA	1.95e-03	29	32	2	M39676
Pathway	WP_LIPID_METABOLISM_PATHWAY	PRKACG PRKACA	1.95e-03	29	32	2	M39762
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY	PRKACG PRKACA	1.95e-03	29	32	2	M47515
Pathway	KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY	PRKACG PRKACA	1.95e-03	29	32	2	M47627
Pathway	WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS	PRKACG PRKACA	2.09e-03	30	32	2	M42578
Pathway	REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS	DOCK1 PRKCE ARPC2	2.15e-03	114	32	3	MM14814
Pathway	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	PRKACG PRKCE PRKACA	2.21e-03	115	32	3	M9387
Pathway	KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY	PRKACG PRKACA	2.23e-03	31	32	2	M47507
Pathway	KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY	PRKACG PRKACA	2.37e-03	32	32	2	M47506
Pathway	WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN	PRKACG PRKACA	2.52e-03	33	32	2	M48071
Pathway	PID_INTEGRIN_A4B1_PATHWAY	DOCK1 PRKACA	2.52e-03	33	32	2	M277
Pathway	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION	PRKACG PRKACA	2.52e-03	33	32	2	M11575
Pathway	WP_GLYCOGEN_METABOLISM	PYGB PYGM	2.68e-03	34	32	2	MM15985
Pathway	KEGG_PRION_DISEASES	PRKACG PRKACA	2.83e-03	35	32	2	M13036
Pathway	PID_GMCSF_PATHWAY	PRKACG PRKACA	3.00e-03	36	32	2	M22
Pathway	REACTOME_CA_DEPENDENT_EVENTS	PRKACG PRKACA	3.16e-03	37	32	2	M749
Pathway	REACTOME_TRIGLYCERIDE_METABOLISM	PRKACG PRKACA	3.33e-03	38	32	2	M27856
Pathway	REACTOME_RET_SIGNALING	PRKACG PRKACA	3.69e-03	40	32	2	M27746
Pathway	WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION	PYGB PYGM	3.69e-03	40	32	2	M39595
Pathway	WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION	PRKACG PRKACA	3.87e-03	41	32	2	M39655
Pathway	REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION	PRKACG PRKACA	4.06e-03	42	32	2	M791
Pathway	REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS	DOCK1 PRKCE ARPC2	4.09e-03	143	32	3	M27107
Pathway	REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION	PRKACG PRKACA	4.25e-03	43	32	2	M29837
Pathway	WP_HEDGEHOG_SIGNALING_WP4249	PRKACG PRKACA	4.25e-03	43	32	2	M39706
Pathway	REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS	PRKACG PRKACA	4.25e-03	43	32	2	M933
Pathway	REACTOME_SMOOTH_MUSCLE_CONTRACTION	SORBS1 DYSF	4.25e-03	43	32	2	M1429
Pathway	KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION	PRKACG PRKACA	4.45e-03	44	32	2	M9011
Pathway	WP_VASOPRESSINREGULATED_WATER_REABSORPTION	PRKACG PRKACA	4.45e-03	44	32	2	M42554
Pathway	REACTOME_GPER1_SIGNALING	PRKACG PRKACA	4.65e-03	45	32	2	M45008
Pathway	WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION	PRKCE MMP16	4.85e-03	46	32	2	M46450
Pathway	PID_LKB1_PATHWAY	SMARCD3 PRKACA	5.06e-03	47	32	2	M87
Pathway	KEGG_TASTE_TRANSDUCTION	PRKACG PRKACA	6.17e-03	52	32	2	M5785
Pathway	KEGG_STARCH_AND_SUCROSE_METABOLISM	PYGB PYGM	6.17e-03	52	32	2	M14171
Pathway	REACTOME_AQUAPORIN_MEDIATED_TRANSPORT	PRKACG PRKACA	6.17e-03	52	32	2	M920
Pathway	PID_NFAT_3PATHWAY	PRKCE PRKACA	6.40e-03	53	32	2	M113
Pathway	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION	PRKACG DOCK1 PRKACA	6.61e-03	170	32	3	M941
Pathway	REACTOME_G_PROTEIN_MEDIATED_EVENTS	PRKACG PRKACA	6.64e-03	54	32	2	M26911
Pathway	KEGG_VIBRIO_CHOLERAE_INFECTION	PRKACG PRKACA	6.64e-03	54	32	2	M17906
Pubmed	Distribution of frequenin in the mouse inner ear during development, comparison with other calcium-binding proteins and synaptophysin.	CALB1 CALB2 NCS1	7.04e-09	4	43	3	11077193
Pubmed	Myosin-I isozymes in neonatal rodent auditory and vestibular epithelia.	MYO1E MYO1H MYO1F	3.51e-08	6	43	3	12486594
Pubmed	Expression of the neuronal calcium sensor protein NCS-1 in the developing mouse olfactory pathway.	CALB1 CALB2 NCS1	1.47e-07	9	43	3	15611992
Pubmed	Membrane-cytoskeletal crosstalk mediated by myosin-I regulates adhesion turnover during phagocytosis.	MYO1E MYO1F	1.49e-06	2	43	2	30890704
Pubmed	Correlation between calbindin expression in granule cells of the resected hippocampal dentate gyrus and verbal memory in temporal lobe epilepsy.	CALB1 CALB2	1.49e-06	2	43	2	22796338
Pubmed	Calbindin expression in adult vestibular epithelia.	CALB1 CALB2	1.49e-06	2	43	2	32350587
Pubmed	Effect of 835 MHz radiofrequency radiation exposure on calcium binding proteins in the hippocampus of the mouse brain.	CALB1 CALB2	1.49e-06	2	43	2	19968972
Pubmed	Inactivation of calcium-binding protein genes induces 160 Hz oscillations in the cerebellar cortex of alert mice.	CALB1 CALB2	1.49e-06	2	43	2	14724241
Pubmed	Different distributions of calbindin and calretinin immunostaining across the medial and dorsal divisions of the mouse medial geniculate body.	CALB1 CALB2	1.49e-06	2	43	2	19643174
Pubmed	Myo1f has an essential role in γδT intraepithelial lymphocyte adhesion and migration.	MYO1E MYO1F	1.49e-06	2	43	2	37207213
Pubmed	Characterization of the cAMP-dependent protein kinase catalytic subunit Cgamma expressed and purified from sf9 cells.	PRKACG PRKACA	1.49e-06	2	43	2	15039079
Pubmed	Isoform-selective regulation of glycogen phosphorylase by energy deprivation and phosphorylation in astrocytes.	PYGB PYGM	1.49e-06	2	43	2	25130497
Pubmed	Loss of calbindin-D28K is associated with the full range of tangle pathology within basal forebrain cholinergic neurons in Alzheimer's disease.	CALB1 CALB2	1.49e-06	2	43	2	26417681
Pubmed	The human calbindin D28k (CALB1) and calretinin (CALB2) genes are located at 8q21.3----q22.1 and 16q22----q23, respectively, suggesting a common duplication with the carbonic anhydrase isozyme loci.	CALB1 CALB2	1.49e-06	2	43	2	1906795
Pubmed	Lipids, obesity and gallbladder disease in women: insights from genetic studies using the cardiovascular gene-centric 50K SNP array.	TTC39B GCKR	1.49e-06	2	43	2	25920552
Pubmed	Absence of the calcium-binding protein calretinin, not of calbindin D-28k, causes a permanent impairment of murine adult hippocampal neurogenesis.	CALB1 CALB2	1.49e-06	2	43	2	22536174
Pubmed	Purkinje cell rhythmicity and synchronicity during modulation of fast cerebellar oscillation.	CALB1 CALB2	1.49e-06	2	43	2	16054763
Pubmed	The scaffolding protein GRASP/Tamalin directly binds to Dock180 as well as to cytohesins facilitating GTPase crosstalk in epithelial cell migration.	DOCK1 TAMALIN	1.49e-06	2	43	2	23441967
Pubmed	Rabies virus infection is associated with variations in calbindin D-28K and calretinin mRNA expression levels in mouse brain tissue.	CALB1 CALB2	1.49e-06	2	43	2	37069450
Pubmed	Mouse fetal trisomy 13 and hypotrophy of the spinal cord: effect on calbindin-D28k and calretinin expressed by neurons of the spinal cord and dorsal root ganglia.	CALB1 CALB2	1.49e-06	2	43	2	8309546
Pubmed	Calretinin and calbindin D-28k, but not parvalbumin protect against glutamate-induced delayed excitotoxicity in transfected N18-RE 105 neuroblastoma-retina hybrid cells.	CALB1 CALB2	1.49e-06	2	43	2	12126880
Pubmed	The human immunodeficiency virus coat protein gp120 promotes forward trafficking and surface clustering of NMDA receptors in membrane microdomains.	PRKACG PRKCE PRKACA	2.31e-06	21	43	3	22114277
Pubmed	Human immunodeficiency virus Tat protein induces interleukin 6 mRNA expression in human brain endothelial cells via protein kinase C- and cAMP-dependent protein kinase pathways.	PRKACG PRKCE PRKACA	2.31e-06	21	43	3	9671211
Pubmed	The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix.	PRKACG PRKCE PRKACA	2.67e-06	22	43	3	9151826
Pubmed	Immunohistochemical Localization of Calbindin D28k, Parvalbumin, and Calretinin in the Superior Olivary Complex of Circling Mice.	CALB1 CALB2	4.48e-06	3	43	2	29130968
Pubmed	Protease-activated receptor 2 sensitizes TRPV1 by protein kinase Cepsilon- and A-dependent mechanisms in rats and mice.	PRKCE PRKACA	4.48e-06	3	43	2	16793902
Pubmed	EF-hand protein Ca2+ buffers regulate Ca2+ influx and exocytosis in sensory hair cells.	CALB1 CALB2	4.48e-06	3	43	2	25691754
Pubmed	Molecular cloning of a tissue-specific protein kinase (C gamma) from human testis--representing a third isoform for the catalytic subunit of cAMP-dependent protein kinase.	PRKACG PRKACA	4.48e-06	3	43	2	2342480
Pubmed	Cell signaling through the protein kinases cAMP-dependent protein kinase, protein kinase Cepsilon, and RAF-1 regulates amphotropic murine leukemia virus envelope protein-induced syncytium formation.	PRKCE PRKACA	4.48e-06	3	43	2	15741175
Pubmed	Cerebellar network plasticity: from genes to fast oscillation.	CALB1 CALB2	4.48e-06	3	43	2	18359574
Pubmed	The role of Pax6 in restricting cell migration between developing cortex and basal ganglia.	CALB1 CALB2	4.48e-06	3	43	2	10572034
Pubmed	Reelin regulates the development and synaptogenesis of the layer-specific entorhino-hippocampal connections.	CALB1 CALB2	4.48e-06	3	43	2	9952412
Pubmed	Abnormalities in the cerebellum and brainstem in homozygous lurcher mice.	CALB1 CALB2	4.48e-06	3	43	2	9252230
Pubmed	Changes in the distribution of calbindin D28-k, parvalbumin, and calretinin in the hippocampus of the circling mouse.	CALB1 CALB2	4.48e-06	3	43	2	22226504
Pubmed	Active cAMP-dependent protein kinase incorporated within highly purified HIV-1 particles is required for viral infectivity and interacts with viral capsid protein.	PRKACG PRKACA	4.48e-06	3	43	2	12842892
Pubmed	Immunohistochemical localization of calbindin D28-k, parvalbumin, and calretinin in the cerebellar cortex of the circling mouse.	CALB1 CALB2	4.48e-06	3	43	2	20691752
Pubmed	Forskolin-mediated BeWo cell fusion involves down-regulation of miR-92a-1-5p that targets dysferlin and protein kinase cAMP-activated catalytic subunit alpha.	DYSF PRKACA	4.48e-06	3	43	2	29484758
Pubmed	Neurodegenerative and morphogenic changes in a mouse model of temporal lobe epilepsy do not depend on the expression of the calcium-binding proteins parvalbumin, calbindin, or calretinin.	CALB1 CALB2	4.48e-06	3	43	2	10771338
Pubmed	Calcium-binding proteins in focal cortical dysplasia.	CALB1 CALB2	4.48e-06	3	43	2	26081613
Pubmed	The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits.	PRKACG PRKACA	4.48e-06	3	43	2	19383776
Pubmed	Calretinin Functions in Malignant Mesothelioma Cells Cannot Be Replaced by the Closely Related Ca2+-Binding Proteins Calbindin-D28k and Parvalbumin.	CALB1 CALB2	4.48e-06	3	43	2	30545133
Pubmed	Early telencephalic migration topographically converging in the olfactory cortex.	CALB1 CALB2	4.48e-06	3	43	2	17878174
Pubmed	Role of phosphorylation in the nuclear biology of HIV-1.	PRKACG PRKCE PRKACA	5.04e-06	27	43	3	21651489
Pubmed	Molecular signatures and cellular diversity during mouse habenula development.	ZFHX2 CALB1 CALB2	5.64e-06	28	43	3	35793630
Pubmed	A role of MAP1B in Reelin-dependent neuronal migration.	CALB1 CALB2	8.94e-06	4	43	2	15590913
Pubmed	Distinct immunohistochemically defined areas in the medial amygdala in the developing and adult mouse.	CALB1 CALB2	8.94e-06	4	43	2	18331873
Pubmed	Class I myosin Myo1e regulates TLR4-triggered macrophage spreading, chemokine release, and antigen presentation via MHC class II.	MYO1E MYO1F	8.94e-06	4	43	2	25263281
Pubmed	Distribution of GABAergic interneurons and dopaminergic cells in the functional territories of the human striatum.	CALB1 CALB2	8.94e-06	4	43	2	22272358
Pubmed	Patterns of expression of calcium binding proteins and neuronal nitric oxide synthase in different populations of hippocampal GABAergic neurons in mice.	CALB1 CALB2	8.94e-06	4	43	2	12115690
Pubmed	Rap1GAP2 is a new GTPase-activating protein of Rap1 expressed in human platelets.	PRKACG PRKACA	8.94e-06	4	43	2	15632203
Pubmed	A humble hexose monophosphate pathway metabolite regulates short- and long-term control of lipogenesis.	PRKACG PRKACA	8.94e-06	4	43	2	12721358
Pubmed	Acidosis Mediates the Switching of Gs-PKA and Gi-PKCε Dependence in Prolonged Hyperalgesia Induced by Inflammation.	PRKCE PRKACA	8.94e-06	4	43	2	25933021
Pubmed	Protein kinase A-induced phosphorylation of the p65 subunit of nuclear factor-kappaB promotes Schwann cell differentiation into a myelinating phenotype.	PRKACG PRKACA	8.94e-06	4	43	2	18385332
Pubmed	Diversity and Connectivity of Layer 5 Somatostatin-Expressing Interneurons in the Mouse Barrel Cortex.	CALB1 CALB2	8.94e-06	4	43	2	29326172
Pubmed	Protein kinase A-dependent phosphorylation of Dock180 at serine residue 1250 is important for glioma growth and invasion stimulated by platelet derived-growth factor receptor α.	DOCK1 PRKACA	8.94e-06	4	43	2	25468898
Pubmed	COUP-TFII is preferentially expressed in the caudal ganglionic eminence and is involved in the caudal migratory stream.	CALB1 CALB2	1.49e-05	5	43	2	19074032
Pubmed	Genetically Defined Subtypes of Somatostatin-Containing Cortical Interneurons.	CALB1 CALB2	1.49e-05	5	43	2	37463742
Pubmed	GRASP and IPCEF promote ARF-to-Rac signaling and cell migration by coordinating the association of ARNO/cytohesin 2 with Dock180.	DOCK1 TAMALIN	1.49e-05	5	43	2	20016009
Pubmed	Embryonic and postnatal development of GABA, calbindin, calretinin, and parvalbumin in the mouse claustral complex.	CALB1 CALB2	1.49e-05	5	43	2	15558732
Pubmed	Effect of Brn-3a deficiency on parvalbumin-, calbindin D-28k-, calretinin- and calcitonin gene-related peptide-immunoreactive primary sensory neurons in the trigeminal ganglion.	CALB1 CALB2	1.49e-05	5	43	2	12150774
Pubmed	Layer positioning of late-born cortical interneurons is dependent on Reelin but not p35 signaling.	CALB1 CALB2	1.49e-05	5	43	2	16452688
Pubmed	Cajal-Retzius neurons are required for the development of the human hippocampal fissure.	CALB1 CALB2	1.49e-05	5	43	2	30861578
Pubmed	HIV-1 Tat binds to SH3 domains: cellular and viral outcome of Tat/Grb2 interaction.	PRKACG PRKACA	1.49e-05	5	43	2	21745501
Pubmed	Pax6-/- mice have a cell nonautonomous defect in nonradial interneuron migration.	CALB1 CALB2	1.49e-05	5	43	2	17634386
Pubmed	HIV-1 gp120 induces anergy in naive T lymphocytes through CD4-independent protein kinase-A-mediated signaling.	PRKACG PRKACA	1.49e-05	5	43	2	12972513
Pubmed	Single-nucleus transcriptomics reveals functional compartmentalization in syncytial skeletal muscle cells.	CALB1 DYSF	1.49e-05	5	43	2	33311457
Pubmed	Effects of [D-Ala1] peptide T-NH2 and HIV envelope glycoprotein gp120 on cyclic AMP dependent protein kinases in normal and psoriatic human fibroblasts.	PRKACG PRKACA	1.49e-05	5	43	2	9540970
Pubmed	PKA-mediated stabilization of FoxH1 negatively regulates ERalpha activity.	PRKACG PRKACA	1.49e-05	5	43	2	19711044
Pubmed	Development of neurons and fibers containing calcium binding proteins in the pallial amygdala of mouse, with special emphasis on those of the basolateral amygdalar complex.	CALB1 CALB2	1.49e-05	5	43	2	15973681
Pubmed	Protein kinases A and C in post-mortem prefrontal cortex from persons with major depression and normal controls.	PRKCE PRKACA	1.49e-05	5	43	2	19573263
Pubmed	Mice lacking IGF-I and LIF have motoneuron deficits in brain stem nuclei.	CALB1 CALB2	1.49e-05	5	43	2	15597051
Pubmed	Normal development of embryonic thalamocortical connectivity in the absence of evoked synaptic activity.	CALB1 CALB2	1.49e-05	5	43	2	12451131
Pubmed	Loss of BETA2/NeuroD leads to malformation of the dentate gyrus and epilepsy.	CALB1 CALB2	1.49e-05	5	43	2	10639171
Pubmed	Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways.	PRKACG PRKACA	1.49e-05	5	43	2	19483721
Pubmed	Oculomotor deficits in aryl hydrocarbon receptor null mouse.	CALB1 CALB2	2.23e-05	6	43	2	23301081
Pubmed	Creatine transporter localization in developing and adult retina: importance of creatine to retinal function.	CALB1 CALB2	2.23e-05	6	43	2	15930147
Pubmed	Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion.	CALB1 CALB2	2.23e-05	6	43	2	18425115
Pubmed	Distinct subtypes of proprioceptive dorsal root ganglion neurons regulate adaptive proprioception in mice.	CALB1 CALB2	2.23e-05	6	43	2	33589589
Pubmed	Roles of semaphorin-6B and plexin-A2 in lamina-restricted projection of hippocampal mossy fibers.	CALB1 CALB2	2.23e-05	6	43	2	20484647
Pubmed	Spatiotemporal patterns of sortilin and SorCS2 localization during organ development.	CALB1 CALB2	2.23e-05	6	43	2	26964886
Pubmed	The transcription factor Foxk1 is expressed in developing and adult mouse neuroretina.	CALB1 CALB2	2.23e-05	6	43	2	23714736
Pubmed	Cxcr4 regulation of interneuron migration is disrupted in 22q11.2 deletion syndrome.	CALB1 CALB2	2.23e-05	6	43	2	23091025
Pubmed	Ser276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammation.	PRKACG PRKACA	2.23e-05	6	43	2	19197368
Pubmed	Highly segregated localization of the functionally related vps10p receptors sortilin and SorCS2 during neurodevelopment.	CALB1 CALB2	2.23e-05	6	43	2	29405286
Pubmed	Tumor necrosis factor receptor-associated factor 6 (TRAF6) deficiency results in exencephaly and is required for apoptosis within the developing CNS.	CALB1 CALB2	2.23e-05	6	43	2	11007897
Pubmed	Msx1 disruption leads to diencephalon defects and hydrocephalus.	CALB1 CALB2	2.23e-05	6	43	2	15188430
Pubmed	Genome-wide association study of suicide attempts in mood disorder patients.	PRKCE SORBS1	2.23e-05	6	43	2	21041247
Pubmed	PKCdelta associates with and is involved in the phosphorylation of RasGRP3 in response to phorbol esters.	PRKCE PRKACA	2.23e-05	6	43	2	15213298
Pubmed	Most classes of dorsal root ganglion neurons are severely depleted but not absent in mice lacking neurotrophin-3.	CALB1 CALB2	2.23e-05	6	43	2	8809809
Pubmed	Protein phosphorylation of human brain glutamic acid decarboxylase (GAD)65 and GAD67 and its physiological implications.	PRKCE PRKACA	2.23e-05	6	43	2	15147202
Pubmed	Frizzled9 protein is regionally expressed in the developing medial cortical wall and the cells derived from this region.	CALB1 CALB2	2.23e-05	6	43	2	15939089
Pubmed	Immunohistochemical analysis of Disc1 expression in the developing and adult hippocampus.	CALB1 CALB2	2.23e-05	6	43	2	18620078
Pubmed	Architectural DNA-binding properties of the spermatidal transition proteins 1 and 2.	PRKACG PRKACA	2.23e-05	6	43	2	9837753
Pubmed	A human MAP kinase interactome.	DOCK1 MACF1 PRKCE SORBS1 EXPH5 PRKACA	2.84e-05	486	43	6	20936779
Pubmed	Genetic variants influencing circulating lipid levels and risk of coronary artery disease.	TTC39B GCKR MYO1H	3.12e-05	49	43	3	20864672
Pubmed	Brn-3a deficiency transiently increases expression of calbindin D-28 k and calretinin in the trigeminal ganglion during embryonic development.	CALB1 CALB2	3.12e-05	7	43	2	19288186
Pubmed	Oncomodulin identifies different hair cell types in the mammalian inner ear.	CALB1 CALB2	3.12e-05	7	43	2	20653034
Pubmed	TRPC5 regulates axonal outgrowth in developing retinal ganglion cells.	CALB1 CALB2	3.12e-05	7	43	2	31844148
Pubmed	Estrogen receptor beta is essential for sprouting of nociceptive primary afferents and for morphogenesis and maintenance of the dorsal horn interneurons.	CALB1 CALB2	3.12e-05	7	43	2	17693550
Pubmed	Downregulation of functional Reelin receptors in projection neurons implies that primary Reelin action occurs at early/premigratory stages.	CALB1 CALB2	3.12e-05	7	43	2	19710317
Cytoband	3p24.3	DAZL EFHB	2.96e-04	27	43	2	3p24.3
Cytoband	8q21.3	CALB1 MMP16	3.42e-04	29	43	2	8q21.3
Cytoband	Ensembl 112 genes in cytogenetic band chr8q21	CALB1 MMP16 STAU2	7.86e-04	192	43	3	chr8q21
Cytoband	Ensembl 112 genes in cytogenetic band chr3p24	DAZL EFHB	5.08e-03	113	43	2	chr3p24
Cytoband	Ensembl 112 genes in cytogenetic band chr15q22	HERC1 MYO1E	6.86e-03	132	43	2	chr15q22
Cytoband	Ensembl 112 genes in cytogenetic band chr9q33	GAPVD1 RABGAP1	7.47e-03	138	43	2	chr9q33
GeneFamily	Myosins, class I	MYO1E MYO1H MYO1F	2.07e-07	8	29	3	1097
GeneFamily	Glycogen phosphorylases	PYGB PYGM	7.45e-06	3	29	2	437
GeneFamily	EF-hand domain containing	MACF1 CALB1 CALB2 EFHB NCS1	2.33e-05	219	29	5	863
Coexpression	GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN	DOCK1 SMARCD3 PYGM MYO1E MYO1F	1.83e-05	199	43	5	M5257
Coexpression	GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_DN	RAD52 UAP1 PNPLA7 EXPH5 AQR	1.87e-05	200	43	5	M6574
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK1 MACF1 PRKCE DYSF MMP16	1.19e-06	194	43	5	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	distal-Endothelial-Capillary_Intermediate_1-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PRKCE SORBS1 CHST2 TAMALIN EXPH5	1.39e-06	200	43	5	43bc48413b100a06f8edd9acd812296788fcbf5b
ToppCell	distal-Endothelial-Capillary_Intermediate_1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PRKCE SORBS1 CHST2 TAMALIN EXPH5	1.39e-06	200	43	5	4d6714d48738cdee7d535923f6dd2431e5304741
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	DAZL CALB1 TAMALIN ARPC2	1.13e-05	144	43	4	e2a2f260f5ebaaef46248d199c407a15ce9d024a
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PAM PYGM CALB2 KLHL40	1.93e-05	165	43	4	c6b23013d77fa9aa967b76e451c8e42b0a657c30
ToppCell	mild_COVID-19_(asymptomatic)-pDC\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	DOCK1 SORBS1 MYO1E EXPH5	2.07e-05	168	43	4	968405ea56f7d001ef83ff9274610923c3b2d55d
ToppCell	PND07-28-samps-Myeloid\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	PNPLA7 ADAP2 ARPC2 MYO1F	2.07e-05	168	43	4	87512f9e5e95333e7ffc6efa1e93bab2ba9154c6
ToppCell	367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PRKCE CHST2 EFHB EXPH5	2.11e-05	169	43	4	225aec04ba762d4c55885257de03a65b63503fbb
ToppCell	367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PRKCE CHST2 EFHB EXPH5	2.11e-05	169	43	4	278960f940b646a788360b1c84d641a8d169896b
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122\|Adult / Lineage, Cell type, age group and donor	PRKCE SORBS1 CHST2 TAMALIN	2.21e-05	171	43	4	bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAM SRPRA CALB1 DYSF	2.42e-05	175	43	4	8b498eea1ec1c1f27b171025c3d08adf3687bafc
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAM SRPRA CALB1 DYSF	2.42e-05	175	43	4	a5db428b078938627e61b7e944c1e0c1d61ac2da
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SMARCD3 PRKCE CALB1 MYO1E	2.83e-05	182	43	4	f96095b81188b52db8fcfca4837129cfcd9bd7b7
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	PAM MACF1 SORBS1 MYO1E	2.95e-05	184	43	4	d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell	Control-Endothelial_cells-Endothelial_cells_(general)\|Control / group, cell type (main and fine annotations)	PRKCE SORBS1 DYSF TAMALIN	3.14e-05	187	43	4	fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122\|Adult / Lineage, Cell type, age group and donor	PRKCE SORBS1 DYSF TAMALIN	3.21e-05	188	43	4	02a62888e9db29d20133eeca1686d302545a39c9
ToppCell	Control-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	PRKCE SORBS1 CHST2 EXPH5	3.21e-05	188	43	4	88b3415e33db81726dd29c1f50c886e057af50a0
ToppCell	COPD-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	PRKCE SORBS1 CHST2 EXPH5	3.21e-05	188	43	4	1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	DOCK1 TTC39B MYO1E EXPH5	3.21e-05	188	43	4	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRKCE CALB1 CALB2 EXPH5	3.27e-05	189	43	4	f57200c93d39c9bce1adba0a6a1c178c028dd86b
ToppCell	COPD-Lymphoid-NK\|Lymphoid / Disease state, Lineage and Cell class	CHST2 TAMALIN ARPC2 MYO1F	3.55e-05	193	43	4	0020249fa71afb500af73700543bb6f349be6b10
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)\|Adult / Lineage, Cell type, age group and donor	PRKCE SORBS1 DYSF TAMALIN	3.55e-05	193	43	4	39c6c96a2a100b1b290a779d36cc6bc17245720b
ToppCell	mLN-T_cell-gd_T\|T_cell / Region, Cell class and subclass	CRYBB2 DYSF MYO1E MYO1F	3.77e-05	196	43	4	8f476408cd5a4ea9d25c763c66565343d7989b38
ToppCell	mLN-T_cell-gd_T\|mLN / Region, Cell class and subclass	CRYBB2 DYSF MYO1E MYO1F	3.85e-05	197	43	4	8ef03bdbd34a874671aebfdbb7111106aa37b2a9
ToppCell	mLN-(1)_T_cell-(17)_gd_T\|mLN / shred on region, Cell_type, and subtype	CRYBB2 DYSF MYO1E MYO1F	3.85e-05	197	43	4	5c781ded147db2f3804ee1f21ef0898c4f354890
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRKCE SORBS1 DYSF TAMALIN	3.85e-05	197	43	4	81718164c9802ee20c860ffbda7e62d5e9a76f16
ToppCell	Control-NK\|Control / Disease condition and Cell class	MACF1 CHST2 ARPC2 MYO1F	4.00e-05	199	43	4	f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRKCE SORBS1 DYSF TAMALIN	4.00e-05	199	43	4	dc88ce36cc066eb6c28cfd5b9b60fe07f8cc7b53
ToppCell	COVID-19_Mild-NK\|COVID-19_Mild / Disease condition and Cell class	CHST2 TAMALIN ARPC2 MYO1F	4.08e-05	200	43	4	b586b0f1127293c2f8529be16b24229359041da2
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRKCE SORBS1 DYSF TAMALIN	4.08e-05	200	43	4	105c67e4f5eff036013d655c8e8ac577d32dae2e
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZFHX2 STAG1 CATSPERD	1.77e-04	113	43	3	357bc20edc5bc14eab8262d52260ed1686e9dc54
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-NK_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZFHX2 STAG1 CATSPERD	1.77e-04	113	43	3	91e73e3b93be242fef0f14eddd8085a1f1c730ef
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Npw\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CALB1 TAMALIN EXPH5	1.77e-04	113	43	3	165de4316059222f33d1e51aeff4554037c0b937
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Fibcd1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	DAZL CALB1 TAMALIN	2.67e-04	130	43	3	c70fb77324916d220d842a575558a8245c276599
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	GCKR CHST2 TAMALIN	2.80e-04	132	43	3	a1fda8c5287168c4f159203ed27cadfb4ce1b131
ToppCell	343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PRKCE CHST2 EXPH5	3.25e-04	139	43	3	2fdc8f36510aff24abbc79ef2a842db75a85f946
ToppCell	343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	PRKCE CHST2 EXPH5	3.25e-04	139	43	3	5970a654c64e3b54f9d18c102f5b125eec892fc5
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	GCKR MYO1F PRKACA	3.46e-04	142	43	3	ae495c8dd733f0fde66bddc281606543f21c0d4b
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Macc1_Lrg1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CALB1 TAMALIN EXPH5	3.46e-04	142	43	3	d08e1880425d285c4433014fe0242ac7ff7734af
ToppCell	BLOOD--(0)_NK_cell-(0)_NK_cells_(CD56dim-like)\|(0)_NK_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	CHST2 ARPC2 MYO1F	3.68e-04	145	43	3	6dd81d53d006fcc206a10969374a11c372f92133
ToppCell	COVID-19_Moderate-multiplets\|COVID-19_Moderate / disease group, cell group and cell class	MACF1 GCKR MYO1F	3.83e-04	147	43	3	baf15c773d7751bc6f64d4974a22738626f2b3ff
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CALB1 TAMALIN EXPH5	3.91e-04	148	43	3	d5cace5605bff2bb8248fadb51f2dad7539930ba
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-lymphoid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SORBS1 CHST2 MMP16	4.23e-04	152	43	3	acfafdb64bd5b0eb7371b04cfef51ed2798e9b30
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-common_lymphoid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SORBS1 CHST2 MMP16	4.23e-04	152	43	3	9d6c88ceca0569dbeb12e488acec7fcb7f972f03
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DOCK1 MYO1E EXPH5	4.31e-04	153	43	3	91e9d70a5d3f6fd68c284ed0cc113f03d7d1e10b
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DOCK1 MYO1E EXPH5	4.31e-04	153	43	3	f17f62646633cf95c810dcd5328978058741b276
ToppCell	RV-17._Lymphocyte\|World / Chamber and Cluster_Paper	CRYBB2 TDRD15 MYO1F	4.47e-04	155	43	3	189276a3b400b2202e6681e23732e6452bfe704e
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Agmat\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CALB1 TAMALIN EXPH5	4.56e-04	156	43	3	09e0702400570089d9012dcf94dfb4827c97e49d
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PYGM CALB2 KLHL40	4.56e-04	156	43	3	896e2d958be0a5c62fb6eebad2dfb7e1ce69f3ad
ToppCell	Control-Endothelial_cells-Inflamed_endothelial_cells\|Control / group, cell type (main and fine annotations)	SORBS1 DYSF TAMALIN	4.91e-04	160	43	3	958256e3d3836160763b82bb48f794087918d935
ToppCell	P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MACF1 PYGM CHST2	5.00e-04	161	43	3	b19f82dd98a3064581793711bb70373f18abecd9
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_5\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CRYBB2 CHST2 TAMALIN	5.00e-04	161	43	3	78cc5bc488bc47726195a649946d414e6bfabf94
ToppCell	10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro-HSC/MPP\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ZFHX2 TTC39B EXPH5	5.00e-04	161	43	3	aee74a2e7a8acd2950341963f1c04b59c7862183
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PYGM CALB2 KLHL40	5.00e-04	161	43	3	be77e99faf653480c166305df3a4e93db76f0dcb
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CALB1 TAMALIN EXPH5	5.00e-04	161	43	3	e3327c296d48e821004e61a573abb75624a6f040
ToppCell	PND07-28-samps-Myeloid-Macrophage\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	PNPLA7 ADAP2 ARPC2	5.09e-04	162	43	3	7c73fe8388af370461e04097cf145cbc9847285b
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_5\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CRYBB2 CHST2 TAMALIN	5.09e-04	162	43	3	0fa93efc9c005d1e649b3f7069ae8641d6e41ed8
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_B2\|390C / Donor, Lineage, Cell class and subclass (all cells)	CRYBB2 CHST2 MYO1F	5.18e-04	163	43	3	036e65de0f8fc391f3e4d299bf4c05ee5c3b5a37
ToppCell	368C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	CHST2 MMP16 EXPH5	5.27e-04	164	43	3	dd29decc6c41a580cfdf03962827ec18d432935f
ToppCell	368C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	CHST2 MMP16 EXPH5	5.27e-04	164	43	3	dcd3c3ee73900180451fad9b4de0efedbd375e1c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SMARCD3 PYGM MMP16	5.37e-04	165	43	3	9de841c1c95967c562720feba930246debc626fd
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SMARCD3 PYGM MMP16	5.37e-04	165	43	3	a612a7d3a5415ecacc3df8fbff0ce498f982aad0
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SMARCD3 PYGM MMP16	5.37e-04	165	43	3	cdc94a640ec01c6892521bcd6f0ee0a66ff23866
ToppCell	mild_COVID-19_(asymptomatic)-pDC\|World / disease group, cell group and cell class (v2)	SORBS1 MYO1E EXPH5	5.56e-04	167	43	3	bf08f17965a4dd03f371b4ed0ab0d5e62ed61307
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D175\|Adult / Lineage, Cell type, age group and donor	SORBS1 MMP16 NCS1	5.56e-04	167	43	3	c4e321bb87512ea839f324c92c0f1afea891483f
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	PRKCE DAZL TAMALIN	5.66e-04	168	43	3	6db453cbbbaf4144a86fadcfa5805d33396713b5
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SMARCD3 CALB1 MYO1E	5.75e-04	169	43	3	0332f539a2f7d6dcd081a5d2f567290721f5a329
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAM MMP16 TAMALIN	5.85e-04	170	43	3	af8b56555cbd5a1016ab9ec2ce88225c58c89648
ToppCell	10x5'-GI_small-bowel-Lymphocytic_NK-NK_CD16\|GI_small-bowel / Manually curated celltypes from each tissue	CHST2 TAMALIN MYO1F	5.95e-04	171	43	3	1ee505b91f15191d294a5d491ecdf154c08b8622
ToppCell	ASK440-Epithelial-Transformed_epithelium\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	SORBS1 CALB2 NCS1	6.06e-04	172	43	3	df3800bcd9777d02900eba0cfc26ab73de8a1d95
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAM MMP16 TAMALIN	6.06e-04	172	43	3	9a1743abcd5fbd38253ea84d88ad716cfb71de36
ToppCell	facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMARCD3 SORBS1 CALB2	6.26e-04	174	43	3	2eee7b5471672b439f95eba11494c2adf8cb7006
ToppCell	facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMARCD3 SORBS1 CALB2	6.26e-04	174	43	3	197686570cec6d96a92e77e6409325d3bfe6f991
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PAM CALB2 KLHL40	6.26e-04	174	43	3	a5f2a4e3b25e6084bd7003a53da86a44f6fcf294
ToppCell	droplet-Kidney-nan-18m-Endothelial-kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GCKR DYSF TAMALIN	6.47e-04	176	43	3	5386386619cf173939d3c117b20e6f27ab397993
ToppCell	droplet-Kidney-nan-18m-Endothelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GCKR DYSF TAMALIN	6.47e-04	176	43	3	820edade963768e4bfd86b554da4cd7100567ac8
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MACF1 PYGM CHST2	6.47e-04	176	43	3	d30241fb8119834d6e7b59efec3f92fc7a3d1247
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAM MACF1 STAG1	6.47e-04	176	43	3	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RABGAP1 PNPLA7 MMP16	6.58e-04	177	43	3	30f82b04e48940bfcaf2c22677efe6d57ae3f1a7
ToppCell	facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SMARCD3 PYGM SORBS1	6.58e-04	177	43	3	928118b0ed120ec01c7d753ce523ab609ac24e5f
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PYGM CALB1 MMP16	6.58e-04	177	43	3	7af1a19692f7fe8f691178a4e57d62bc379e3d56
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGM GCKR KLHL40	6.69e-04	178	43	3	69f68eeab11b088fcb1f963c92eff0f1cd0e711a
ToppCell	B_cells-Naive_B_cells_\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	PRKCE PNPLA7 MYO1E	6.69e-04	178	43	3	71ac2eca5cf13a91f86b80690748b0788392dcfc
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CALB2 EXPH5 MYO1F	6.91e-04	180	43	3	6ac62bf1251978c8c12e715f7b73144fca619794
ToppCell	droplet-Limb_Muscle-Pre-Sort\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAM SORBS1 MYO1H	6.91e-04	180	43	3	af2bafcd1b2082629de3ea336711add01565c4c4
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PRKCE SORBS1 DYSF	6.91e-04	180	43	3	d8ef44710a77ad0fc03243428e5e1dc4d41200cb
ToppCell	Control-Endothelial_cells-Capillary_endothelial_cells\|Control / group, cell type (main and fine annotations)	PRKCE SORBS1 TAMALIN	6.91e-04	180	43	3	b043f9ffb9a4cd427a15bebb86a711c7b08866e8
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	CHST2 EXPH5 RPS19BP1	6.91e-04	180	43	3	310a311c3ed924c912a800cf287a825de44b8775
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SMARCD3 CALB1 MYO1E	6.91e-04	180	43	3	788d5fbf688365b5d92d3aa19b9f8e9448f8be5a
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAM SORBS1 MYO1H	6.91e-04	180	43	3	f29a995cf6e1a1836ed68b73258d9370bf3d4434
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_PP_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAM CALB1 NCS1	7.13e-04	182	43	3	eb4be1c02b8b033d025e57b8b4cdbfaec4698054
ToppCell	CTRL-Myeloid-cDC\|Myeloid / Disease state, Lineage and Cell class	CHST2 TAMALIN NCS1	7.13e-04	182	43	3	ee137574b8f0e684a4a7cb26226877c471cae433
ToppCell	COVID-19_Mild-gd_T\|COVID-19_Mild / Disease condition and Cell class	MACF1 SRPRA MYO1F	7.25e-04	183	43	3	f593a89b0aa8fffdfa403769916facfd30358521
ToppCell	CTRL-Myeloid-cDC\|CTRL / Disease state, Lineage and Cell class	CHST2 TAMALIN NCS1	7.25e-04	183	43	3	20c4d16de7e090df3556a4458f783383a26871b6
ToppCell	metastatic_Brain-Endothelial_cells-Stalk-like_ECs\|metastatic_Brain / Location, Cell class and cell subclass	DOCK1 GCKR TAMALIN	7.48e-04	185	43	3	ad52970e88e8947ef256095bd4b40229b912d58a
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231\|Adult / Lineage, Cell type, age group and donor	SORBS1 DYSF TAMALIN	7.48e-04	185	43	3	07f9f38f0739d7c830641723a38385550ac1ac92
ToppCell	normal-na-Lymphocytic_NK-NK_dim-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	CHST2 ARPC2 MYO1F	7.48e-04	185	43	3	b1a8a8c4d0fc7605eabc17dcb6bd9e8ab4fd578c
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAM CALB1 NCS1	7.48e-04	185	43	3	4e40d3103ebf4a7066b7ce300b6ef700ba0e2863
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	TTC39B MACF1 GAPVD1	7.48e-04	185	43	3	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	P03\|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MACF1 PYGM CHST2	7.48e-04	185	43	3	a07dbe1f76e40734a28826423a5cc64b8e56af5e
Drug	8-azido cyclic AMP	PRKACG PYGB PYGM PRKACA	3.31e-08	18	43	4	CID000115296
Drug	AC1Q6RZ4	PRKACG PYGB PYGM UAP1 GCKR PRKACA	1.14e-07	123	43	6	CID000000719
Drug	AC1L19C4	PRKACG PYGB PYGM GCKR PRKACA	1.94e-07	69	43	5	CID000000483
Drug	allulose 6-phosphate	PRKACG PYGB PYGM UAP1 GCKR PRKACA	5.80e-07	162	43	6	CID000000603
Drug	AC1Q6RZL	PRKACG PYGB PYGM PRKACA	1.85e-06	47	43	4	CID000001144
Drug	Starlicide	PRKACG PYGB PYGM PRKACA	2.20e-06	49	43	4	CID000007255
Drug	3,5-dimethylphenyl isocyanate	PYGB PYGM	1.04e-05	3	43	2	CID000521488
Drug	5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone	PYGB PYGM	1.04e-05	3	43	2	CID000093111
Drug	adenosine-5'-chloromethylphosphonate	PYGB PYGM	1.04e-05	3	43	2	CID000191554
Drug	hydan	PYGB PYGM	1.04e-05	3	43	2	CID000008360
Drug	EHMF	PYGB PYGM	1.04e-05	3	43	2	CID000033931
Drug	5'-deoxy-5'-fluoro-5'-(methylthio)adenosine	PYGB PYGM	1.04e-05	3	43	2	CID000147839
Drug	pyridoxal 5'-methylenephosphonate	PYGB PYGM	1.04e-05	3	43	2	CID003082249
Drug	Plp 5'-mpa	PYGB PYGM	1.04e-05	3	43	2	CID003082151
Drug	glucose-1,2-cyclic phosphate	PYGB PYGM	1.04e-05	3	43	2	CID000191723
Drug	3'-FFdUrd	PYGB PYGM	1.04e-05	3	43	2	CID000072260
Drug	2',3',4',5,5'-pentachloro-2-biphenylol	PYGB PYGM	1.04e-05	3	43	2	CID000119518
Drug	AC1L8XK3	PYGB PYGM	1.04e-05	3	43	2	CID000409735
Drug	N-acetyl-N'-beta-D-glucopyranosyl urea	PYGB PYGM	1.04e-05	3	43	2	CID000446801
Drug	NSC758405	PYGB PYGM	1.04e-05	3	43	2	CID000003201
Drug	3,5-dinitrophenyl phosphate	PYGB PYGM	1.04e-05	3	43	2	CID000151920
Drug	riboflavin tetraacetate	PYGB PYGM	1.04e-05	3	43	2	CID000094186
Drug	pyridoxal phosphoglucose	PYGB PYGM	1.04e-05	3	43	2	CID000196007
Drug	2,5-dimethyl-3-furanone	PYGB PYGM	1.04e-05	3	43	2	CID000085730
Drug	3,5-dinitrophenol	PYGB PYGM	1.04e-05	3	43	2	CID000011459
Drug	2',3'-dideoxyadenosine	PRKACG PYGB PYGM PRKACA	1.73e-05	82	43	4	CID000020039
Drug	galocitabine	PYGB PYGM	2.09e-05	4	43	2	CID000065950
Drug	2,5-anhydro-D-mannitol 1-phosphate	PYGB PYGM	2.09e-05	4	43	2	CID000189134
Drug	AC1LAMW2	PYGB PYGM	2.09e-05	4	43	2	CID000491364
Drug	FdUrd-C8	PYGB PYGM	2.09e-05	4	43	2	CID000094262
Drug	Mem-CC	PYGB PYGM	2.09e-05	4	43	2	CID003081269
Drug	5-deoxyribose-1-phosphate	PYGB PYGM	2.09e-05	4	43	2	CID000135786
Drug	ingliforib	PYGB PYGM	2.09e-05	4	43	2	CID006451325
Drug	uric acid riboside	PYGB PYGM	2.09e-05	4	43	2	CID000164933
Drug	pseudo-dl-glucose	PYGB PYGM	2.09e-05	4	43	2	CID000125259
Drug	BCIp4A	PYGB PYGM	2.09e-05	4	43	2	CID000192417
Drug	pyridoxal diphosphate	PYGB PYGM	2.09e-05	4	43	2	CID000125696
Drug	3'-chloromethotrexate	PYGB PYGM	2.09e-05	4	43	2	CID000097703
Drug	1-o-phosphonohex-2-ulose	PYGB PYGM GCKR	2.22e-05	29	43	3	CID000000481
Drug	2,5-anhydro-D-mannitol	PYGB PYGM GCKR	2.72e-05	31	43	3	CID000001494
Drug	quin2	PYGB PRKCE PYGM CALB1	3.10e-05	95	43	4	CID000104841
Drug	Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; PC3; HT_HG-U133A	RAD52 SORBS1 MMP16 MYO1F PRKACA	3.24e-05	195	43	5	5115_UP
Drug	Quinic acid [86-68-0]; Down 200; 19.6uM; HL60; HT_HG-U133A	RAD52 MACF1 SRPRA EXPH5 PRKACA	3.32e-05	196	43	5	2978_DN
Drug	Y-27632; Down 200; 3uM; MCF7; HT_HG-U133A_EA	MACF1 SRPRA STAG1 MMP16 MYO1F	3.32e-05	196	43	5	832_DN
Drug	Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A	RAD52 RABGAP1 CALB2 MMP16 ADAP2	3.40e-05	197	43	5	3862_DN
Drug	Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; PC3; HT_HG-U133A	GAPVD1 RABGAP1 MMP16 NCS1 PRKACA	3.40e-05	197	43	5	5811_DN
Drug	heptulose-2-P	PYGB PYGM	3.47e-05	5	43	2	CID000124823
Drug	m-anisidine	PYGB PYGM	3.47e-05	5	43	2	CID000010824
Drug	6-FPLP	PYGB PYGM	3.47e-05	5	43	2	CID000146246
Drug	gluconohydroximo-1,5-lactone	PYGB PYGM	3.47e-05	5	43	2	CID009576855
Drug	2-hydroxypropylphosphonate	PYGB PYGM	3.47e-05	5	43	2	CID000441028
Drug	DHPBU	PYGB PYGM	3.47e-05	5	43	2	CID000125914
Drug	6-FDPL	PYGB PYGM	3.47e-05	5	43	2	CID000129578
Drug	5'-isobutylthioinosine	PYGB PYGM	3.47e-05	5	43	2	CID003080910
Drug	3'-O-methylpyridoxal 5'-phosphate	PYGB PYGM	3.47e-05	5	43	2	CID003082179
Drug	GlcMan	PYGB PYGM	3.47e-05	5	43	2	CID000152120
Drug	U66985	PYGB PYGM	3.47e-05	5	43	2	CID000127224
Drug	indirubin-5-sulphonate	PYGB PYGM	3.47e-05	5	43	2	CID005288641
Drug	AC1O3M08	PYGB PYGM	3.47e-05	5	43	2	CID006331955
Drug	AC1LCUXJ	PYGB PYGM	3.47e-05	5	43	2	CID000656425
Drug	6-amino-5-bromouracil	PYGB PYGM	3.47e-05	5	43	2	CID000080578
Drug	etafenone	PYGB PYGM	3.47e-05	5	43	2	CID000003275
Drug	ddEtUrd	PYGB PYGM	3.47e-05	5	43	2	CID000451452
Drug	5-trifluoromethyl-2'-deoxycytidine	PYGB PYGM	3.47e-05	5	43	2	CID000125618
Drug	Isoflupredone acetate [338-98-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A	DOCK1 RAD52 CRYBB2 ZFHX2 MYO1F	3.48e-05	198	43	5	5545_DN
Drug	Milrinone [78415-72-2]; Up 200; 19uM; MCF7; HT_HG-U133A	RAD52 RABGAP1 CALB1 CALB2 AQR	3.48e-05	198	43	5	7210_UP
Drug	Sulindac [38194-50-2]; Up 200; 11.2uM; PC3; HT_HG-U133A	RAD52 ZFHX2 PRKCE RABGAP1 MYO1F	3.56e-05	199	43	5	5103_UP
Drug	Gliclazide [21187-98-4]; Up 200; 12.4uM; MCF7; HT_HG-U133A	PRKCE CALB1 CALB2 EXPH5 PRKACA	3.56e-05	199	43	5	2870_UP
Drug	Suxibuzone [27470-51-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A	RAD52 RABGAP1 DYSF MMP16 ADAP2	3.56e-05	199	43	5	7163_UP
Drug	carbocyanine	CALB1 CALB2 DYSF	4.29e-05	36	43	3	CID000017704
Drug	Heptachlor Epoxide	TTC39B PRKCE TAMALIN MYO1F	4.42e-05	104	43	4	ctd:D006534
Drug	CV-araU	PYGB PYGM	5.20e-05	6	43	2	CID006441877
Drug	2-thiothymidine	PYGB PYGM	5.20e-05	6	43	2	CID003005944
Drug	Carbocyclic Bvdc	PYGB PYGM	5.20e-05	6	43	2	CID006438602
Drug	DNPP	PYGB PYGM	5.20e-05	6	43	2	CID000067056
Drug	5-chloro-indole-2-carboxylic acid	PYGB PYGM	5.20e-05	6	43	2	CID000082693
Drug	2,2-dimethyl-3-hydroxybutyric acid	PYGB PYGM	5.20e-05	6	43	2	CID000152984
Drug	EdUMP	PYGB PYGM	5.20e-05	6	43	2	CID003085112
Drug	5'-deoxy-5'-chloroformycin	PYGB PYGM	5.20e-05	6	43	2	CID000126430
Drug	NSC-97433	PYGB PYGM	5.20e-05	6	43	2	CID000001803
Drug	5-n-propylthioadenosine	PYGB PYGM	5.20e-05	6	43	2	CID000656428
Drug	AzddCyd	PYGB PYGM	5.20e-05	6	43	2	CID000451374
Drug	5-Ffdru	PYGB PYGM	5.20e-05	6	43	2	CID000065561
Drug	AR-L57	PYGB PYGM	5.20e-05	6	43	2	CID000156890
Drug	Carbocyclic Ivdu	PYGB PYGM	5.20e-05	6	43	2	CID006439191
Drug	3 SA	PRKACG ARPC2 PRKACA	6.36e-05	41	43	3	CID000449164
Drug	alpha-(fluoromethyl)dehydroornithine	PYGB PYGM	7.27e-05	7	43	2	CID006439607
Drug	6-fluoropyridoxal	PYGB PYGM	7.27e-05	7	43	2	CID003080803
Drug	2',3'-dideoxy-3'-fluorocytidine	PYGB PYGM	7.27e-05	7	43	2	CID000356019
Drug	heptenitol	PYGB PYGM	7.27e-05	7	43	2	CID000188267
Drug	AC1L3372	PYGB PYGM	7.27e-05	7	43	2	CID000108025
Drug	1 Gpt	PYGB PYGM	7.27e-05	7	43	2	CID000101247
Drug	formycins	PYGB PYGM	7.27e-05	7	43	2	CID000512867
Drug	Promonta	PYGB PYGM	7.27e-05	7	43	2	CID000108494
Drug	5'-methylthioinosine	PYGB PYGM	7.27e-05	7	43	2	CID000161214
Drug	hydantocidin	PYGB PYGM	7.27e-05	7	43	2	CID000125429
Drug	NPC 15437	PRKACG PRKCE PRKACA	9.00e-05	46	43	3	CID000004548
Drug	chloroethylclonidine	PYGB PRKCE PYGM	9.60e-05	47	43	3	CID000104973
Drug	AC1NUVX5	PYGB PYGM	9.69e-05	8	43	2	CID005461894
Drug	6-methylpurine	PYGB PYGM	9.69e-05	8	43	2	CID005287547
Disease	lipoprotein measurement	DOCK1 TTC39B TDRD15 GCKR MYO1H	4.48e-07	105	43	5	EFO_0004732
Disease	lipoprotein measurement, phospholipid measurement	TTC39B TDRD15 GCKR MYO1H	7.26e-06	85	43	4	EFO_0004639, EFO_0004732
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	TTC39B TDRD15 MACF1 GCKR STAG1	1.87e-05	225	43	5	EFO_0008317, EFO_0020947
Disease	phospholipids:total lipids ratio	TTC39B TDRD15 MACF1 GCKR STAG1	1.96e-05	227	43	5	EFO_0020946
Disease	mental or behavioural disorder, attempted suicide	PRKCE SORBS1	2.07e-05	5	43	2	EFO_0000677, EFO_0004321
Disease	sleep duration, high density lipoprotein cholesterol measurement	TTC39B MACF1 STAG1 MYO1H	2.93e-05	121	43	4	EFO_0004612, EFO_0005271
Disease	glucagon measurement, glucose tolerance test	MACF1 HERC1	3.10e-05	6	43	2	EFO_0004307, EFO_0008463
Disease	fatty acid measurement	TTC39B TDRD15 MACF1 GCKR STAG1 MYO1H	3.86e-05	436	43	6	EFO_0005110
Disease	choline measurement	TTC39B TDRD15 GCKR MYO1H	3.89e-05	130	43	4	EFO_0010116
Disease	complex trait	TDRD15 PYGB MACF1 GAPVD1 GCKR	4.56e-05	271	43	5	EFO_0010578
Disease	phosphoglycerides measurement	TDRD15 GCKR MYO1H	4.76e-05	48	43	3	EFO_0022291
Disease	triglyceride measurement, high density lipoprotein cholesterol measurement	TTC39B TDRD15 GCKR STAG1 MYO1H	4.80e-05	274	43	5	EFO_0004530, EFO_0004612
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	TTC39B TDRD15 MACF1 GCKR MYO1H	4.97e-05	276	43	5	EFO_0004612, EFO_0020943
Disease	cholesteryl esters to total lipids in small VLDL percentage	TTC39B TDRD15 GCKR	5.07e-05	49	43	3	EFO_0022256
Disease	phospholipid measurement	TTC39B TDRD15 GCKR MYO1H	5.19e-05	140	43	4	EFO_0004639
Disease	phosphatidylcholine measurement	TTC39B TDRD15 MACF1 GCKR MYO1H	5.69e-05	284	43	5	EFO_0010226
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	TTC39B TDRD15 MACF1 GCKR	5.79e-05	144	43	4	EFO_0004611, EFO_0020943
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	TTC39B TDRD15 MACF1 GCKR	6.79e-05	150	43	4	EFO_0004611, EFO_0020947
Disease	Uveitis	CRYBB2 CALB2	7.42e-05	9	43	2	C0042164
Disease	worry measurement	PAM GAPVD1 STAG1 MYO1H	7.51e-05	154	43	4	EFO_0009589
Disease	phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement	TTC39B TDRD15 MACF1 GCKR MYO1H	8.22e-05	307	43	5	EFO_0004612, EFO_0020946
Disease	total lipids in medium HDL measurement	TTC39B GCKR MYO1H	8.41e-05	58	43	3	EFO_0022310
Disease	free cholesterol in medium HDL measurement	TTC39B GCKR MYO1H	8.41e-05	58	43	3	EFO_0022267
Disease	Uterine leiomyoma, estrogen-receptor negative breast cancer	EXPH5 ADAP2	9.27e-05	10	43	2	EFO_1000650, HP_0000131
Disease	phospholipids in HDL measurement	TTC39B GCKR MYO1H	9.78e-05	61	43	3	EFO_0022293
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	TTC39B TDRD15 GCKR MYO1H	1.00e-04	166	43	4	EFO_0004530, EFO_0004611
Disease	total lipids in HDL measurement	TTC39B GCKR MYO1H	1.08e-04	63	43	3	EFO_0022307
Disease	total lipids in very large HDL measurement	TTC39B TDRD15 GCKR	1.24e-04	66	43	3	EFO_0022312
Disease	cholesterol in very large HDL measurement	TTC39B TDRD15 GCKR	1.41e-04	69	43	3	EFO_0022229
Disease	alcohol use disorder (implicated_via_orthology)	PRKACG SMARCD3 PRKCE PRKACA	1.87e-04	195	43	4	DOID:1574 (implicated_via_orthology)
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	TDRD15 MACF1 GCKR MYO1H	2.06e-04	200	43	4	EFO_0004611, EFO_0020945
Disease	free cholesterol in large HDL measurement	TTC39B GCKR MYO1H	2.11e-04	79	43	3	EFO_0022157
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	TTC39B TDRD15 MACF1 GCKR	3.06e-04	222	43	4	EFO_0008317, EFO_0020943
Disease	lipid measurement, lipoprotein measurement	TTC39B TDRD15 GCKR	3.10e-04	90	43	3	EFO_0004529, EFO_0004732
Disease	Cholecystitis	TTC39B GCKR	3.49e-04	19	43	2	HP_0001082
Disease	Hypertriglyceridemia	TDRD15 GCKR	3.49e-04	19	43	2	EFO_0004211
Disease	apolipoprotein B measurement	TTC39B TDRD15 PYGB SRPRA GCKR STAG1	3.78e-04	663	43	6	EFO_0004615
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	TTC39B TDRD15 MACF1 GCKR	4.04e-04	239	43	4	EFO_0008317, EFO_0020945
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	TDRD15 MACF1 GCKR STAG1	4.30e-04	243	43	4	EFO_0004612, EFO_0020944
Disease	neurotic disorder	STAG1 MYO1H RPS19BP1	4.35e-04	101	43	3	EFO_0004257
Disease	gallstones	TTC39B GCKR ARPC2	5.29e-04	108	43	3	EFO_0004210
Disease	cholesteryl ester measurement	TTC39B TDRD15 GCKR STAG1	5.31e-04	257	43	4	EFO_0010351
Disease	level of Phosphatidylethanolamine (16:0_18:2) in blood serum	GCKR MYO1E	5.61e-04	24	43	2	OBA_2045136
Disease	coronary artery disease, factor VII measurement	TDRD15 GCKR STAG1	5.73e-04	111	43	3	EFO_0001645, EFO_0004619
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	TTC39B TDRD15 MACF1 GCKR	5.88e-04	264	43	4	EFO_0008317, EFO_0020944
Disease	macular telangiectasia type 2	TTC39B GCKR	6.59e-04	26	43	2	EFO_1002009
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	TDRD15 MACF1 GCKR	7.36e-04	121	43	3	EFO_0008595, EFO_0020943
Disease	platelet component distribution width	PYGB MACF1 GAPVD1 CHST2 HERC1 ARPC2	7.48e-04	755	43	6	EFO_0007984
Disease	level of Phosphatidylethanolamine (18:0_18:2) in blood serum	GCKR MYO1E	7.65e-04	28	43	2	OBA_2045139
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	TTC39B TDRD15 MACF1 GCKR	8.45e-04	291	43	4	EFO_0008317, EFO_0020946
Disease	esterified cholesterol measurement	TTC39B TDRD15 GCKR	8.67e-04	128	43	3	EFO_0008589
Disease	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	GAPVD1 MYO1E	8.79e-04	30	43	2	C1868672
Disease	polyunsaturated fatty acid measurement	TTC39B TDRD15 GCKR	9.27e-04	131	43	3	EFO_0010733
Disease	cholesteryl esters to total lipids in large LDL percentage	TTC39B GCKR	9.39e-04	31	43	2	EFO_0022249
Disease	free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	TTC39B TDRD15 GCKR MYO1H	9.81e-04	303	43	4	EFO_0004612, EFO_0020945
Disease	social communication impairment	DOCK1 MYO1E	1.00e-03	32	43	2	EFO_0005427
Disease	sexual dimorphism measurement	TTC39B MACF1 GAPVD1 HERC1 DYSF ADAP2 MYO1F	1.01e-03	1106	43	7	EFO_0021796
Disease	cortical thickness	PAM PYGB MACF1 RABGAP1 DYSF STAU2 ARPC2	1.05e-03	1113	43	7	EFO_0004840
Disease	total cholesterol measurement, high density lipoprotein cholesterol measurement	TTC39B TDRD15 GCKR MYO1H	1.13e-03	315	43	4	EFO_0004574, EFO_0004612
Disease	free cholesterol measurement, high density lipoprotein cholesterol measurement	TTC39B TDRD15 GCKR MYO1H	1.13e-03	315	43	4	EFO_0004612, EFO_0008591
Disease	SAPHO syndrome	PRKACG DYSF	1.20e-03	35	43	2	EFO_1001164
Disease	free cholesterol in small HDL measurement	TDRD15 GCKR	1.20e-03	35	43	2	EFO_0022270
Disease	phospholipid measurement, high density lipoprotein cholesterol measurement	TTC39B TDRD15 GCKR MYO1H	1.21e-03	321	43	4	EFO_0004612, EFO_0004639
Disease	lipid measurement, high density lipoprotein cholesterol measurement	TTC39B TDRD15 GCKR MYO1H	1.34e-03	330	43	4	EFO_0004529, EFO_0004612
Disease	apolipoprotein A 1 measurement	TTC39B MACF1 GCKR HERC1 STAG1 MYO1H	1.36e-03	848	43	6	EFO_0004614
Disease	low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	TTC39B TDRD15 GCKR	1.45e-03	153	43	3	EFO_0004611, EFO_0020946
Disease	low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	TTC39B TDRD15 GCKR	1.45e-03	153	43	3	EFO_0004611, EFO_0020944

Protein segments in the cluster

Peptide	Gene	Start	Entry
GYEQANCKGEQFVFE	CRYBB2	61	P43320
FIIEKEFYDPGFQGQ	CATSPERD	541	Q86XM0
EKYFQFQEEGKEGEN	ARPC2	126	O15144
DGNSFDSKFVYQQIG	PAM	536	P19021
KFYTGFEINDQTGNA	AQR	306	O60306
FTEEDFQKFQQEYFG	RPS19BP1	121	Q86WX3
QVFLGNKEQGYEAYE	ADAP2	301	Q9NPF8
QNVDFVDLNNGKFYV	RAD52	91	P43351
FDYGLRELFKQNFED	RABGAP1	676	Q9Y3P9
DQQGYIQVTDFGFAK	PRKACA	176	P17612
GQLDAAGFQKIYKQF	NCS1	41	P62166
NQEEFKGFSYFGEDL	PRKCE	721	Q02156
QFVDGYKQLGFQETA	GAPVD1	81	Q14C86
NLGFYTDQAFGELEK	HERC1	951	Q15751
FQVEQIGENKYRFGD	MACF1	3266	O94854
YGIFGKEQQLAFLEN	EXPH5	1886	Q8NEV8
TKENQVFVAGGLFYN	KLHL40	356	Q2TBA0
VFVAGGLFYNEDNKE	KLHL40	361	Q2TBA0
KEDNQTFGFEIQTYG	TAMALIN	106	Q7Z6J2
LDFGKFNEICEVGYQ	PNPLA7	1181	Q6ZV29
FEYEGNFIQKFQREL	GCKR	466	Q14397
DQQGYLQVTDFGFAK	PRKACG	176	P22612
FNQLYENKGEADFVE	DOCK1	756	Q14185
FNKAFELYDQDGNGY	CALB1	191	P05937
VDNDGFINYLEFANF	EFHB	611	Q8N7U6
DGNGYIEGKELENFF	CALB2	31	P22676
GYGFVSFFNDVDVQK	DAZL	81	Q92904
IQFEVSIGNYGNKFD	DYSF	611	O75923
EFQVYFVDFGNKQLV	TDRD15	1041	B5MCY1
DKEYINGDKYFQQIF	SMARCD3	301	Q6STE5
GELFNQNPEVFFLYE	CHST2	181	Q9Y4C5
KNKLQQEFFYEFEGG	TTC39B	286	Q5VTQ0
NFGFELVIQYNEGKQ	ZFHX2	1446	Q9C0A1
YENSDGNFVFFKGNK	MMP16	396	P51512
NDFNLKDFNVGGYIQ	PYGM	251	P11217
FYVQLTVGNNEFFGE	STAU2	146	Q9NUL3
VLEYGEAIAKFNFNG	SORBS1	866	Q9BX66
NDFKLQDFNVGDYIE	PYGB	251	P11216
YKLDNQFELVFVVGF	SRPRA	56	P08240
GIEFAFKYQNQKGQE	STAG1	981	Q8WVM7
NFEELNFFFQKAIEG	UAP1	41	Q16222
VLDIYGFEIFQKNGF	MYO1E	386	Q12965
GFEIFQKNGFEQFCI	MYO1E	391	Q12965
DIYGFEIFQKNGFEQ	MYO1F	386	O00160
DIYGFEVFDKNGFEQ	MYO1H	391	Q8N1T3
EVFDKNGFEQFCINY	MYO1H	396	Q8N1T3